Article
T₂-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism - 1 May 2014
Evans Matthew C, Serres Sébastien, Khrapitchev Alexandre A, Stolp Helen B, Anthony Daniel C, Talbot Kevin, Turner Martin R, Sibson Nicola R
Abstract excerpt
Neuroinflammation has been identified as a potential therapeutic target in amyotrophic lateral sclerosis (ALS), but relevant biomarkers are needed. The superoxide dismutase (SOD1)(G93A) transgenic mouse model of ALS offers a unique opportunity to study and potentially manipulate presymptomatic pathology. While T₂-weighted magnetic resonance imaging (MRI) has been shown to be sensitive to pathologic changes at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
